Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05798780 · ClinicalTrials.gov registry record · NA

The ENHANCE Study: Exercise and Nutrition in Head And Neck CancEr Survivors

A NA study of Oropharynx Cancer and Oral Cavity Cancer, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

Active
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT05798780 is a NA study of Oropharynx Cancer and Oral Cavity Cancer that is active but no longer recruiting, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 40 participants, below the 131-participant average among 26 other Oropharynx Cancer trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05798780, a NA study of Oropharynx Cancer and Oral Cavity Cancer, is active but no longer recruiting, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to design a physical activity and dietary intervention for head and neck cancer patients.

Interventions

  • BEHAVIORAL ENHANCE Intervention - Exercise and Nutrition
  • BEHAVIORAL ENHANCE Intervention - Nutrition Only

Study Locations (1)

Florida

  • Moffitt Cancer Center - Tampa

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2023-04-06
Est. Completion 2026-07
Phase NA

What the Registry Record Tells You About NCT05798780

The ClinicalTrials.gov registry entry for NCT05798780 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 131-participant average among 26 other Oropharynx Cancer trials with a reported enrollment target (69% lower). The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Oropharynx Cancer appearing as the primary indexed condition, and to 2 interventions - of which ENHANCE Intervention - Exercise and Nutrition is the first listed.

NCT05798780 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT05798780 about?

NCT05798780 is a clinical study titled "The ENHANCE Study: Exercise and Nutrition in Head And Neck CancEr Survivors". The purpose of the study is to design a physical activity and dietary intervention for head and neck cancer patients.

What is the current status of trial NCT05798780?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2023-04-06. Estimated completion is 2026-07.

What conditions does trial NCT05798780 study?

This clinical trial studies the following conditions: Oropharynx Cancer, Oral Cavity Cancer, Larynx Cancer, Hypopharynx Cancer.

What interventions are being tested in trial NCT05798780?

The interventions under investigation include: ENHANCE Intervention - Exercise and Nutrition (BEHAVIORAL), ENHANCE Intervention - Nutrition Only (BEHAVIORAL).

Who is sponsoring clinical trial NCT05798780?

This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05798780 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Oropharynx Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.